Screener
Eikon Therapeutics, Inc. EIKN Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Eikon Therapeutics, Inc.’s reported figures.
The source filing: Eikon Therapeutics, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216791
FAQ
- What is Eikon Therapeutics, Inc.'s free cash flow?
- Eikon Therapeutics, Inc. (EIKN) reported free cash flow of -$90.06M in Q1 2026.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Eikon Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude